Epilepsiezentrum Erlangen
Erlangen, Bavaria, 91054, Germany
NCT Number: NCT01178437
The aim of the study is to prove the feasibility and safety of transcutaneous, electrical stimulation of the vagus nerve in patients with difficult-to-treat forms of epilepsy.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Erlangen, Bavaria, 91054, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
daily, transcutaneous, electrical stimulation of the vagus nerve by the t-VNS device for a period of 9 months
Other names: T-VNS® Stimulator cM02
Time frame: 9 months
rated by investigator
QOLIE-89 MADRS CCTE
Time frame: 9 months
rated by patient. Subjective assessment of epileptic shocks and cognitive functions. Measured with "Erlanger Kognitionstest" (EKT)
Time frame: 9 months
EEG long-term monitoring, MR spectroscopy
Time frame: 9 months
Registration of (S)AEs and drop outs
cerbomed GmbH
Industry
Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy - a Prospective Pilot Study Regarding Safety, Effectiveness and Clinical Performance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04770337
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT00088452
Brain Diseases, Central Nervous System Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT00041951
Brain Diseases, Central Nervous System Diseases
New York, United States
View Trial DetailsNCT00361010
Brain Diseases, Central Nervous System Diseases
Cleveland, Ohio, United States
View Trial Details